Concepedia
Statistics
Publications
5
Citations
932
H-Index
Active since
2018
Affiliations
Massachusetts General Hospital(Current)
Harvard University
University of California, Irvine
Cornell University
Center for Cancer Research
Kylie Prutisto-Chang is an author at Massachusetts General Hospital specializing in oncology, medicine, and molecular oncology.
Publications per year
2018–2021
Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound <i>ALK</i> Mutations in ALK-Positive Lung Cancer
Satoshi Yoda, Michael S. Lawrence, Benjamin J. Burke et al. · Cancer Discovery · 2018 · 306 citations · Full text
Medicine, Molecular Medicine, Oncology +16
Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer
Stephen V. Liu, Caroline E. McCoach, Viola W. Zhu et al. · Annals of Oncology · 2020 · 227 citations · Full text
Medicine, Oncology, Pharmacology +17
MET Alterations Are a Recurring and Actionable Resistance Mechanism in ALK-Positive Lung Cancer
Ibiayi Dagogo‐Jack, Satoshi Yoda, Jochen K. Lennerz et al. · Clinical Cancer Research · 2020 · 194 citations · Full text
Spectrum of Mechanisms of Resistance to Crizotinib and Lorlatinib in <i>ROS1</i> Fusion–Positive Lung Cancer
Noura J. Choudhury, Satoshi Yoda, Viola W. Zhu et al. · Clinical Cancer Research · 2021 · 139 citations · Full text
Small cell transformation of ROS1 fusion-positive lung cancer resistant to ROS1 inhibition
Adam Langenbucher, Pranav Gupta, Satoshi Yoda et al. · npj Precision Oncology · 2020 · 66 citations · Full text
Medicine, Genetics, Oncology +17
1–5 of 5